Joachim Rehse

This inventor holds 11 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 10 EPO patents. Top assignees: Bayer Intellectual Property Gmbh, Adverio Pharma Gmbh, Aicuris Gmbh + Co. Kg.. Active years: 2008-2020.

USPTO Granted Patents = 11 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 10 (Patent Applications = 10)

Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 98(Granted Patents)

Company Filing History:

5 out of 721

Bayer Intellectual Property Gmbh

Aicuris Gmbh + Co. Kg.

patents

4. 1 out of 77

Bayer Healthcare Aktiengesellschaft

Years Active: 2008-2020

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10822305 - Process for the preparation of 4-(4-amino-3-fluorophenoxy)-N-methylpyyridine-2-carboxamide (2020-11-03),

2. 10570130 - Process for preparing methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound (2020-02-25),

3. 10351562 - Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound (2019-07-16),

4. 10030014 - Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound (2018-07-24),

5. 9458107 - [object Object] (2016-10-04),

6. 9340535 - N-[5-(Aminosulfony1)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate (2016-05-17),

7. 8853398 - Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound (2014-10-07),

8. 8748622 - [object Object] (2014-06-10),

9. 8501945 - Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate and its purification for use as pharmaceutically active compound (2013-08-06),

10. 8492544 - Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridin-3-yl]pyrimidin-5-yl}Methylcarbamate and its purification for use as pharmaceutically active compound (2013-07-23),

11. 7351823 - Preparation process (2008-04-01),

Title: Joachim Rehse: Innovator in Pharmaceutical Chemistry

Introduction

Joachim Rehse is a notable inventor based in Leichlingen, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 11 patents. His work focuses on innovative processes for the preparation of various pharmaceutical compounds.

Latest Patents

Among his latest patents is a process for the preparation of 4-(4-amino-3-fluorophenoxy)-N-methylpyridine-2-carboxamide. This invention relates to a method for preparing 4-{4-[({[4-chloro-3-(trifluoromethyl)-phenyl]amino}carbonyl)amino]-3-fluorophenoxy}-N-methylpyridine-2-carboxamide, along with its salts and monohydrate. Another significant patent involves the process for preparing methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as a pharmaceutically active compound. This invention details a method for purifying the crude product of the compound for pharmaceutical applications.

Career Highlights

Throughout his career, Joachim Rehse has worked with prominent companies in the pharmaceutical industry, including Bayer Intellectual Property GmbH and Adverio Pharma GmbH. His expertise in the field has allowed him to develop innovative solutions that contribute to advancements in drug development.

Collaborations

Joachim has collaborated with esteemed colleagues such as Franz-Josef Mais and Winfried Joentgen. These partnerships have further enhanced his research and development efforts in pharmaceutical chemistry.

Conclusion

Joachim Rehse's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the industry. His innovative processes continue to impact the development of new pharmaceutical compounds.